Russia’s Sechenov University claims world’s first COVID-19 vaccine
At a time when pharma and biotech companies worldwide are racing to develop a vaccine, researchers at the University of
Read more
DISEASES
Sanofi and GSK close to reaching $624 Million U.K. Vaccine Deal
Sanofi and GlaxoSmithKline are close to reaching a 500 million-pound ($624 million) deal to supply the United Kingdom government with
Read more
Tesla to help COVID-19 vaccine developer CureVac with molecule printers
Tesla Inc is engineering mobile molecule printers to help produce the future COVID-19 vaccine developed by CureVac in Germany, the
Read more
WHO declares second deadliest DR Congo Ebola outbreak is over
The World Health Organization (WHO) and the Democratic Republic of Congo (DRC) government announced on June 25 that the second-largest
Read more
Clover begins trials of COVID-19 vaccine with Dynavax and GSK adjuvants
The Chinese company Clover Biopharmaceuticals revealed the start of a randomized, double-blind, human stage Phase I placebo-controlled clinical study to
Read more
Corticosteroid Dexamethasone could be a lifeline for COVID-19 patients
The initial Dexamethasone clinical trial outcomes in the UK have demonstrated that the generic corticosteroid medication could present a lifeline
Read more
New high CBD cannabis sativa could be effective against SARS-CoV2
Recent Canada-based research studies on cannabis sativa extract with high CBD content are demonstrating encouraging outcomes, such as inhibiting the
Read more
AstraZeneca to supply up to 400 million doses of Oxford’s vaccine free
AstraZeneca has come to an agreement with the European Inclusive Vaccines Alliance (IVA), initiated by Germany, France, Italy and the
Read more
Reinstated hydroxychloroquine study reveals the dangers of rushed trials
The World Health Organisation (WHO) halted one arm of the hydroxychloroquine COVID-19 Trial at the end of May, only to
Read more
Algernon gets FDA nod for human study of Ifenprodil for COVID-19
Algernon has received the FDA’s approval for the commencement of a Phase 2 and 3 human study of it’s repurposed
Read more